Description
Dehydroepiandrosterone BSA Conjugate
| Catalog number: | B2012108 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 0.5 mg |
| Molecular Weight or Concentration: | na |
| Supplied as: | Liquid |
| Applications: | molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | DHEA, Androstenolone, 3-Hydroxyandrost-5-en-17-one BSA |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Rutkowski K, Sowa P, Rutkowska-Talipska J, Kuryliszyn-Moskal A, Rutkowski R. Dehydroepiandrosterone (DHEA): hypes and hopes Drugs. 2014 Jul;74(11):1195-207.
- Aoki K, Terauchi Y. Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and Obesity Vitam Horm. 2018;108:355-365.
- Friess E, Schiffelholz T, Steckler T, Steiger A. Dehydroepiandrosteronea neurosteroid Eur J Clin Invest. 2000 Dec;30 Suppl 3:46-50.
- Pepping J. DHEA: dehydroepiandrosterone Am J Health Syst Pharm. 2000 Nov 15;57(22):2048-50, 2053-4, 2056.
- Arlt W. Dehydroepiandrosterone and ageing Best Pract Res Clin Endocrinol Metab. 2004 Sep;18(3):363-80.
- Kushnir VA, Darmon SK, Barad DH, Weghofer A, Gleicher N. Effects of dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal infertile women Endocrine. 2019 Mar;63(3):632-638.
- Corrigan AB. Dehydroepiandrosterone and sport Med J Aust. 1999 Aug 16;171(4):206-8.
- Arlt W. Dehydroepiandrosterone replacement therapy Semin Reprod Med. 2004 Nov;22(4):379-88.
- Gurnell EM, Chatterjee VK. Dehydroepiandrosterone replacement therapy Eur J Endocrinol. 2001 Aug;145(2):103-6.
